• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Host Microbe . Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2

tetano

Editor, Senior Moderator
Cell Host Microbe


. 2020 Sep 3;S1931-3128(20)30503-5.
doi: 10.1016/j.chom.2020.09.002. Online ahead of print.
Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2


Sandra C A Nielsen[SUP] 1 [/SUP], Fan Yang[SUP] 1 [/SUP], Katherine J L Jackson[SUP] 2 [/SUP], Ramona A Hoh[SUP] 1 [/SUP], Katharina R?ltgen[SUP] 1 [/SUP], Grace H Jean[SUP] 3 [/SUP], Bryan A Stevens[SUP] 1 [/SUP], Ji-Yeun Lee[SUP] 1 [/SUP], Arjun Rustagi[SUP] 4 [/SUP], Angela J Rogers[SUP] 5 [/SUP], Abigail E Powell[SUP] 6 [/SUP], Molly Hunter[SUP] 7 [/SUP], Javaria Najeeb[SUP] 8 [/SUP], Ana R Otrelo-Cardoso[SUP] 8 [/SUP], Kathryn E Yost[SUP] 9 [/SUP], Bence Daniel[SUP] 1 [/SUP], Kari C Nadeau[SUP] 10 [/SUP], Howard Y Chang[SUP] 11 [/SUP], Ansuman T Satpathy[SUP] 1 [/SUP], Theodore S Jardetzky[SUP] 12 [/SUP], Peter S Kim[SUP] 13 [/SUP], Taia T Wang[SUP] 14 [/SUP], Benjamin A Pinsky[SUP] 1 [/SUP], Catherine A Blish[SUP] 15 [/SUP], Scott D Boyd[SUP] 16 [/SUP]



Affiliations

Abstract

B cells are critical for the production of antibodies and protective immunity to viruses. Here we show that patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who develop coronavirus disease 2019 (COVID-19) display early recruitment of B cells expressing a limited subset of IGHV genes, progressing to a highly polyclonal response of B cells with broader IGHV gene usage and extensive class switching to IgG and IgA subclasses with limited somatic hypermutation in the initial weeks of infection. We identify convergence of antibody sequences across SARS-CoV-2-infected patients, highlighting stereotyped naive responses to this virus. Notably, sequence-based detection in COVID-19 patients of convergent B cell clonotypes previously reported in SARS-CoV infection predicts the presence of SARS-CoV/SARS-CoV-2 cross-reactive antibody titers specific for the receptor-binding domain. These findings offer molecular insights into shared features of human B cell responses to SARS-CoV-2 and SARS-CoV.

Keywords: B cells; COVID-19; SARS-CoV-2; antibodies; antibody repertoire; clonal expansion; convergent antibody response; immunogenetics; immunology; primary infection.
 
Back
Top Bottom